English
Sun Pharmaceutical Industries Q2 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,669.20
-31.35 (-1.84%)
-31.35 (-1.84%)Volume1.24 M
Updated: Fri 16 Jan, 2026 | 15:45:56
NSE
1,671.10-29.60 (-1.74%)
-29.60 (-1.74%)Volume3.70 M
Updated: Fri 16 Jan, 2026 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹14,478.31 Cr.(8.93%)
- Operating Profit₹3,367.08 Cr.(5.72%)
- Profit After Tax₹3,117.95 Cr.(2.56%)
- Operating Margin23.26%(-2.95%)
Note: Comparison is on YoY basis
Quarterly - Sun Pharmaceutical Industries Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 11,111.23 | 11,297.33 | -1.65% | 10,106.43 | 9.94% |
| Depreciation/ Amortization | 729.50 | 700.55 | 4.13% | 625.91 | 16.55% |
| Operating Income | 3,367.08 | 2,554.07 | 31.83% | 3,184.96 | 5.72% |
| Net Income | 3,117.95 | 2,278.63 | 36.83% | 3,040.16 | 2.56% |
| Other Operating Expenses Total | 4,634.21 | 4,162.36 | 11.34% | 4,308.62 | 7.56% |
| Net Income Before Taxes | 4,167.61 | 3,172.77 | 31.36% | 3,597.88 | 15.84% |
| Total Revenue | 14,478.31 | 13,851.40 | 4.53% | 13,291.39 | 8.93% |
| Selling/ General/ Admin Expenses Total | 2,764.79 | 2,801.66 | -1.32% | 2,477.70 | 11.59% |
| Diluted Normalized EPS | 13.00 | 11.45 | 13.56% | 12.70 | 2.36% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.